Tyler E. Miller

COVID-19-neutralizing antibodies predict disease severity and survival

Wilfredo F. García-Beltrán, Evan C. Lam, Michael G. Astudillo et al. · Cell · 2020 · 793 citations · Full text

Pharmacy, Immunology, Infectious Diseases +12

MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1

Tyler E. Miller, Kalpana Ghoshal, Bhuvaneswari Ramaswamy et al. · Journal of Biological Chemistry · 2008 · 750 citations · Full text

Medicine, Molecular Biology, Oncology +17

Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients

Anita Iyer, Forrest K. Jones, Ariana Nodoushani et al. · Science Immunology · 2020 · 691 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance

Brian B. Liau, Cem Sievers, Laura K. Donohue et al. · Cell stem cell · 2016 · 531 citations · Full text

Medicine, Cancer Biology, Oncology +16

Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo

Fadi J. Najm, Mayur Madhavan, Anita Zaremba et al. · Nature · 2015 · 422 citations

Life Sciences, Cell Biology, Neuroscience +12